4.7 Article

Predicting Development of Proliferative Diabetic Retinopathy

期刊

DIABETES CARE
卷 36, 期 6, 页码 1562-1568

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc12-0790

关键词

-

资金

  1. National Eye Institute K23 Mentored Clinician Scientist Award [1K23EY019511-01]
  2. Midwest Eye Bank [EY020582]
  3. Physician-Scientist Award from Research to Prevent Blindness
  4. Taubman Institute, Alliance for Vision Research, Blue Cross Blue Shield of Michigan Foundation
  5. Research to Prevent Blindness
  6. Michigan Center for Diabetes Translational Research from the National Institute of Diabetes and Digestive and Kidney Diseases [P30DK092926]

向作者/读者索取更多资源

OBJECTIVE-Identifying individuals most at risk for diabetic retinopathy progression and intervening early can limit vision loss and reduce the costs associated with managing more advanced disease. The purpose of this study was to identify factors associated with progression from nonproliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR). RESEARCH DESIGN AND METHODS-This was a retrospective cohort analysis using a claims database of all eye care recipients age >= 30 years enrolled in a large managed-care network from 2001 to 2009. Individuals with newly diagnosed NPDR were followed longitudinally. Multivariable Cox regression analyses identified factors associated with progression to PDR. Three- and five-year probabilities of retinopathy progression were determined. RESULTS-Among the 4,617 enrollees with incident NPDR, 307 (6.6%) developed PDR. After adjustment for confounders, every 1-point increase in HbA(1c) was associated with a 14% (adjusted hazard ratio 1.14 [95% CI 1.07-1.21]) increased hazard of developing PDR. Those with nonhealing ulcers had a 54% (1.54 [1.15-2.07]) increased hazard of progressing to PDR, and enrollees with nephropathy had a marginally significant increased hazard of progressing to PDR (1.29 [0.99-1.67]) relative to those without these conditions. The 5-year probability of progression for low-risk individuals with NPDR was 5% (range 2-8) and for high-risk patients was 38% (14-55). CONCLUSIONS-Along with glycemic control, nonophthalmologic manifestations of diabetes mellitus (e.g., nephropathy and nonhealing ulcers) are associated with an increased risk of diabetic retinopathy progression. Our retinopathy progression risk score can help clinicians stratify patients who are most at risk for disease progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据